Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)

SHA:688373 Revenue

Shanghai MicuRx Pharmaceutical had revenue of 33.75M CNY in the quarter ending June 30, 2025, with 21.75% growth. This brings the company's revenue in the last twelve months to 136.50M, up 24.77% year-over-year. In the year 2024, Shanghai MicuRx Pharmaceutical had annual revenue of 130.27M with 43.51% growth.

• Revenue (ttm): 136.50M
• Revenue Growth: +24.77%
• P/S Ratio: 34.53
• Revenue / Employee: 771.21K
• Employees: 188
• Market Cap: 4.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	130.27M	39.50M	43.51%
Dec 31, 2023	90.78M	42.57M	88.31%
Dec 31, 2022	48.21M	40.55M	529.33%
Dec 31, 2021	7.66M	-	-
Dec 31, 2020	-	-	-